Applied Evidence

Strategies for caring for the well cancer survivor

Author and Disclosure Information

 

References

Chemotherapies that are more likely to cause cognitive symptoms include methotrexate, 5-fluorouracil, cyclophosphamide, and hormone antagonists.47 More powerful regimens and repetitive chemotherapy regimens tend to cause more cognitive effects.47

Cognitive training interventions show evidence of likely benefit,44,48 leading to recommendations for self-treatment strategies, such as written lists, wordplay, crossword puzzles, jigsaw puzzles, playing a musical instrument, and new hobbies. Small studies suggest a benefit from cognitive behavioral therapy.44,49 A study of breast cancer survivors showed that yoga led to improvement in patient-reported cognitive dysfunction.50 Physical exercise yields cognitive benefit in healthy older adults and is supported by limited evidence in cancer survivors.51

There is no effective pharmacotherapy for cancer- and cancer chemotherapy-related cognitive dysfunction unless a treatable underlying cause is found.44 Symptoms tend to subside with time after completion of chemotherapy, which might be reassuring to patients and families.45

Psychiatric problems. The most common psychiatric issues in cancer survivors are anxiety and depression; the prevalence of anxiety is nearly double that of depression.52 Anxiety often presents as fear of a recurrence of cancer or a feeling of lack of control over present or future circumstances.53 Screening for anxiety and depression is recommended at each visit, using standardized screening questionnaires.54

A small study suggests that psychiatric treatment reduces the risk of early mortality.55 Small studies also suggest that mindfulness-based therapy and cognitive behavioral therapy delivered by telehealth offer benefit.56 A meta-analysis shows that exercise interventions improve depression and anxiety in breast cancer patients.57

Continue to: There are few studies of pharmacotherapy...

Pages

Recommended Reading

MRI doubles rate of observation in low-risk prostate cancer
MDedge Family Medicine
Top cancer researcher fails to disclose corporate financial ties in major research journals
MDedge Family Medicine
Hormonal contraceptive use linked to leukemia risk in offspring
MDedge Family Medicine
Colonoscopy: Should 45 be the new 50?
MDedge Family Medicine
Can tai chi tame seniors’ risk of falls?
MDedge Family Medicine
Growth lateral to right eye
MDedge Family Medicine
NELSON trial: CT Screening reduces lung cancer deaths
MDedge Family Medicine
Does America have a gabapentinoid problem?
MDedge Family Medicine
FDA approves oral dacomitinib for some metastatic NSCLC
MDedge Family Medicine
Researchers share Nobel Prize for cancer immunotherapy discoveries
MDedge Family Medicine